Pentostatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Pentostatin Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Aug 27, 2026. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-0801-01
- Dosage Form
- Injection
- Presentation
- Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
- Initial Posting
- Aug 27, 2026
Reason
Other